Passa al contenuto
Merck

A polymer-based systemic hemostatic agent.

Science advances (2020-08-11)
Yongsheng Gao, Apoorva Sarode, Nikolaos Kokoroskos, Anvay Ukidve, Zongmin Zhao, Shihui Guo, Robert Flaumenhaft, Anirban Sen Gupta, Noelle Saillant, Samir Mitragotri
ABSTRACT

Uncontrolled noncompressible hemorrhage is a major cause of mortality following traumatic injuries in civilian and military populations. An injectable hemostat for point-of-care treatment of noncompressible hemorrhage represents an urgent medical need. Here, we describe an injectable hemostatic agent via polymer peptide interfusion (HAPPI), a hyaluronic acid conjugate with a collagen-binding peptide and a von Willebrand factor-binding peptide. HAPPI exhibited selective binding to activated platelets and promoted their accumulation at the wound site in vitro. In vivo studies in mouse tail vein laceration model demonstrated a reduction of >97% in both bleeding time and blood loss. A 284% improvement in the survival time was observed in the rat inferior vena cava traumatic model. Lyophilized HAPPI could be stably stored at room temperature for several months and reconstituted during therapeutic intervention. HAPPI provides a potentially clinically translatable intravenous hemostat.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
N-idrossisolfosuccinimide, ≥98% (HPLC)
Sigma-Aldrich
Casein Blocking Buffer 10x, for Northern and Southern blotting, solution
Sigma-Aldrich
Collagene di tipo IV umano
Sigma-Aldrich
3,3′-Dihexyloxacarbocyanine iodide, 98%